Clinical Implications of the Evidence from IV Iron Trials in Heart Failure

Published: Nov. 3, 2023, 4 a.m.

Host: Stefan D. Anker, MD, PhD
\n\n Guest: Robert J. Mentz, MD, FHFSA, FACC, FAHA
\n\n Guest: Piotr Ponikowski, MD, PhD, FESC, FHFA
\n\n\n \n

Iron deficiency is an independent predictor of decreased functional capacity and reduced survival in our patients with heart failure. Multiple clinical trials have addressed the issue, but we continue to struggle with the clinical implications of the data. Join Drs. Stefan Anker, Robert Mentz, and Piotr Ponikowski as they discuss the evidence from IV iron trials in heart failure, past and present, and what the results mean for your practice and patients.